S. 1695 (110th): Biologics Price Competition and Innovation Act of 2007


Jun 26, 2007
110th Congress, 2007–2009

Died in a previous Congress

This bill was introduced on June 27, 2007, in a previous session of Congress, but was not enacted.


Edward “Ted” Kennedy

Senator from Massachusetts



Read Text »
Last Updated: Nov 19, 2008
Length: 88 pages

About the bill

Full Title

A bill to amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, to promote innovation in the life sciences, and for other purposes.

Summary (CRS)

Biologics Price Competition and Innovation Act of 2007 - Amends the Public Health Service Act to allow a person to submit an application for licensure of a biological product based ... Read more >

The bill’s title was written by its sponsor.


Jun 26, 2007

This is the first step in the legislative process.

Jun 27, 2007
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

This is a Senate bill in the United States Congress (indicated by the “S.” in “S. 1695”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


4 cosponsors (2R, 2D) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: